Overall rank by patents
#29,986
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 8 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS).
The verdict
Scopio holds 9 US patents across 8 technology areas, rank #29,986 of 50,000 tracked assignees.
Scopio LABS Ltd. has been granted 9 US utility patents between 2020 and 2024, placing Scopio LABS Ltd. at rank #29,986 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.1 claims per patent with primary concentration in G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS). As a Foreign Corporation, Scopio LABS Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Scopio sits between SC2N (9 patents, rank #29,982) and Seattle Children's Research Institute (9 patents, rank #29,990) - the closest US assignees by grant volume. The composite Innovation Score of 43.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Scopio LABS Ltd.'s 20.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Scopio LABS Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SC2N
9 patents
SCANLAB GmbH
9 patents
SCHOTT GEMTRON CORP.
9 patents
SCIENCONS AS
9 patents
SD BIOSENSOR, INC.
9 patents
SDI (NORTH AMERICA), INC.
9 patents
SEAHORSE BIOSCIENCE
9 patents
SEATTLE CHILDREN'S RESEARCH INSTITUTE
9 patents
SCOPIO LABS LTD.
9 patents
What this shows Scopio holds 9 patents at rank #29,986, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,986 in granted patent volume.
Other assignees with the most granted patents in Scopio's primary technology class.
Scopio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 28% higher than 72% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 22.2% |
| 2021 | 1 | 11.1% |
| 2022 | 2 | 22.2% |
| 2023 | 3 | 33.3% |
| 2024 | 1 | 11.1% |
Top 8 of 8 technology areas
Overall rank by patents
#29,986
Across all tracked assignees
43.4 out of 100
How to use this portfolio
Scopio's 9 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.